JPRN-jRCTs041180162招募中未知
sefulness of kestose for the patients with NAFLD and NASH
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients diagnosed as NAFLD/NASH
排除标准
- •1.Women with pregnancy or possible pregnancy
- •2.Patients with severe renal failure and heart failure
- •3.Patient who is considered to be inappropriate for entry into the trial by the investigator
- •4.Medical doctors decided the patients are inappropriate.
- •5.Patients with substantial alcohol consumption (20g/day for women or >30g/day for men).
- •6.Patients with poor glycemic control (HbA1c>9.0%)
- •7.Patients with other active hepatitis and hepatocellular carcinoma
- •8.Patients with history of gastrointestinal surgery
- •9.Patients who take nonabsorbable antibiotic
研究者
相似试验
已完成
不适用
sefulness of kestose for the patients with NAFLD and NASHonalcoholic fatty liver disease/Nonalcoholic steatohepatitisJPRN-UMIN000027058agoya University Hospital60
招募中
1 期
Evaluation of the effectness of kestose in unresectable pancreatic cancerunresectable pancreatic cancerJPRN-jRCTs041200109Hirooka Yoshiki40
已完成
2 期
Ketohexokinase Inhibition in NAFLDNAFLDNCT05463575Maastricht University Medical Center15
招募中
不适用
Efficacy and safety of lacosamide in patients with erythromelalgia due to SCN9A gene mutatioerythromelalgiaJPRN-UMIN000028778niversity of the Ryukyus Hospital1
招募中
2 期
Efficacy and safety of lacosamide in patients with erythromelalgia due to SCN9A gene mutatioFamilial erythromelalgiaJPRN-jRCTs071180055Takahashi Kenzo6